WASHINGTON, DC — Patients who received the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) in the ABSORB-3 trial showed a primary outcome, counting only events occurring between the ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. ATLANTA (AP) — Kyle Farmer just shrugged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results